Early detection of cardiac involvement in patients with sarcoidosis by a non-invasive method with ultrasonic tissue characterisation

Heart

Volumn 90, Issue 11, 2004, Pages 1275-1280

  Hyodo, E ^a   Hozumi, T ^a   Takemoto, Y ^a   Watanabe, H ^a   Muro, T ^a   Yamagishi, H ^a   Yoshiyama, M ^a   Takeuchi, K ^a   Yoshikawa, J ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM 67; THALLIUM 201;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DYSPNEA; EARLY DIAGNOSIS; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE WALL; HEART MUSCLE BIOPSY; HEART SCINTISCANNING; HEART VENTRICLE SEPTUM; HUMAN; MALE; NON INVASIVE MEASUREMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPRODUCIBILITY; SARCOIDOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ULTRASOUND; VISUAL IMPAIRMENT;

CARDIOMYOPATHIES; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY;

EID: 7244258857     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.027763     Document Type: Article

References (26)

1. Mitchell DN, du Bois RM, Oldershaw PJ. Cardiac sarcoidosis. BMJ 1997;314:320-1.
2. Sirverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978;58:1204-11.
3. Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest 1993;103:253-8.
4. Burstow DJ, Tajik AJ, Boiley KR, et al. Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol 1989;63:478-82.
5. Masuyama T, Nellessen U, Schnittger I, et al. Ultrasonic tissue characterization with a real time integrated backscatter imaging system in normal and aging human hearts. J Am Coll Cardiol 1989;14:1702-8.
6. Takiuchi S, Ita H, Iwakura K, et al. Ultrasonic tissue characterization predicts myocardial viability in early stage of reperfused acute myocardial infarction. Circulation 1998;97:356-62.
7. Mura T, Ota T, Watanabe H, et al. Prediction of contractile reserve by cyclic variation of integrated backscatter of the myocardium in patients with chronic left ventricular dysfunction. Heart 2001;85:165-70.
8. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997;336:1224-34.
9. Okayama K, Kurata C, Tawarahara K, et al. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 1995;107:330-4.
10. Okumura W, Iwasaki T, Ueda T, et al. [Usefulness of 18F-FDG PET for diagnosis of cardiac sarcoidosis]. Kaku Igaku 1999;36:341-8.
11. Takeda N, Yokoyama I, Hiroi Y, et al. Positron emission tomography predicted recovery of complete A-V nodal dysfunction in a patient with cardiac sarcoidosis. Circulation 2002;105:1144-5.
12. Yamagishi H, Shirai N, Takagi M, et al. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. J Nucl Med 2003;44:1030-6.
13. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
14. Wickline SA, Thomas LJ, Miller JG, et al. The dependence of myocardial ultrasonic integrated backscatter on contractile performance. Circulation 1985;72:183-92.
15. Wickline SA, Thomas LJ, Miller JG, et al. Sensitive detection of the effects of reperfusion on myocardium by ultrasonic tissue characterization with integrated backscatter. Circulation 1986;74:389-400.
16. Goens MB, Karr SS, Martin GR. Cyclic variation of integrated ultrasound backscatter: normal and abnormal myocardial patterns in children. J Am Soc Echocardiogr 1996;9:616-21.
17. Barzilai B, Madaras EI, Sobel BE, et al. Effects of myocardial contraction on ultrasonic backscatter before and after ischemia. Am J Physiol 1984;247:H478-83.
18. Ferez JE, McGill JB, Santiago JV, et al. Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. J Am Coll Cardiol 1992;19:1154-62.
19. Masuyama T, Valantine HA, Gibbons R, et al. Serial measurement of integrated ultrasonic backscatter in human cardiac allografts (or the recognition of acute rejection. Circulation 1990;81:829-39.
20. Koyama J, Ray-Sequin PA, Falk RH. Prognostic significance of ultrasound myocardial tissue characterization in patients with cardiac amyloidosis. Circulation 2002;106:556-61.
21. Di Bello V, Giorgi D, Talini E, et al. Incremental value of ultrasonic tissue characterization (backscatter) in the evaluation of left ventricular myocardial structure and mechanics in essential arterial hypertension. Circulation 2003;107:74-80.
22. Lieback E, Hardouin I, Meyer R, et al. Clinical value of echocardiographic tissue characterization in the diagnosis of myocarditis. Eur Heart J 1996;17:135-42.
23. Matsui Y, Iwai K, Tachibana T, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci 1976;278:455-09.
24. Holland MR, Wilkenshoff UM, Finch-Johnstan AE, et al. Effects of myocardial fiber orientation in echocardiography: quantitative measurements and computer simulation of the regional dependence of backscattered ultrasound in the parasternal short-axis view. J Am Soc Echocordiogr 1998;11:929-37.
25. Uemura A, Morimota S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 1999;138:299-302.
26. Ratner SJ, Fenoglio JJ Jr, Ursell PC. Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis. Chest 1986;90:528-33.